Admetsys' FDA Breakthrough Designation Accelerates Arrival of Fully Autonomous Clinical Robotics in Hospital
Posted:
Admetsys Corporation, a biomedical technology company specializing in critical care automation, announced today that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
A major workforce optimisation programme has started at the Countess of Chester Hospital NHS Foundation Trust in partnership with workforce planning specialists, SARD.
Read more here.
Nursing education is really no longer limited to textbooks and clinical rotations. The accelerated embrace of digital technologies is transforming the way future nurses learn, with education becoming more accessible, flexible and interactive. Technology, ranging from AI-powered tutoring systems to…
Attendees
Sponsors and
Exhibitors
AI Training
for Doctors Workshops
Contact us